Prevail Therapeutics

New York
New York
United States

Show jobs for this employer

About Prevail Therapeutics

Prevail Therapeutics is a biotechnology company focused on developing novel biologic therapies for Parkinson’s Disease and other neurodegenerative diseases. Prevail was launched in 2017 by The Silverstein Foundation for Parkinson’s with GBA, REGENXBIO, and OrbiMed, and is headquartered in New York, NY.
YEAR FOUNDED:
2017
LEADERSHIP:
Founders: Silverstein Foundation for Parkinson’s with GBA, REGENXBIO, OrbiMed, and Asa Abeliovich

39 articles with Prevail Therapeutics